The Discounted Cash Flow (DCF) valuation of CanSino Biologics Inc (688185.SS) is (432.02) CNY. With the latest stock price at 66.14 CNY, the upside of CanSino Biologics Inc based on DCF is -753.2%.
Based on the latest price of 66.14 CNY and our DCF valuation, CanSino Biologics Inc (688185.SS) is a sell. selling 688185.SS stocks now will result in a potential gain of 753.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.2% | 8.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (830.59) - (300.82) | (432.02) |
| Upside | -1355.8% - -554.8% | -753.2% |